ConductScience.org, home

Paper29436639

Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling.

Tan JY and 5 others. Mol Med Rep, 2018. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling. Papers, record 29436639. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29436639

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling.
PubMed
Journal
Mol Med Rep
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2021-11-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tan JYJia-Ying
2Zhao FFeng
3Deng SXShui-Xiang
4Zhu HCHe-Chen
5Gong YYe
6Wang WWei

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Glycyrrhizic AcidMajor topic
HMGB1 ProteinMajor topic
MonocytesMajor topic
Signal TransductionMajor topic
Cell Line
Cell Movement
Chemokine CCL2
Extracellular Signal-Regulated MAP Kinases
Humans
Mitogen-Activated Protein Kinases
NF-kappa B

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
40070780Glycyrrhizin enhances the antitumor activity of cisplatin in non‑small cell lung cancer cells by influencing DNA damage and apoptosis.Oncol Lett2025https://conductscience.org/library/papers/40070780PubMed
38802470Trimebutine prevents corneal inflammation in a rat alkali burn model.Sci Rep2024https://conductscience.org/library/papers/38802470PubMed
38771510Glycyrrhizic Acid Alleviates Semen Strychni-Induced Neurotoxicity Through the Inhibition of HMGB1 Phosphorylation and Inflammatory Responses.J Neuroimmune Pharmacol2024https://conductscience.org/library/papers/38771510PubMed
37601451Effect of HMGB1 and HBD-3 levels in the diagnosis of sepsis- A comparative descriptive study.Biochem Biophys Rep2023https://conductscience.org/library/papers/37601451PubMed
37446230Inflammation of Dry Eye Syndrome: A Cellular Study of the Epithelial and Macrophagic Involvement of NFAT5 and RAGE.Int J Mol Sci2023https://conductscience.org/library/papers/37446230PubMed
36906519Association of HMGB1 levels in synovial fluid with the severity of temporomandibular joint osteoarthritis.BMC Musculoskelet Disord2023https://conductscience.org/library/papers/36906519PubMed
36313350Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid.Front Pharmacol2022https://conductscience.org/library/papers/36313350PubMed
35646138Medication Rules in Herbal Medicine for Mild Cognitive Impairment: A Network Pharmacology and Data Mining Study.Evid Based Complement Alternat Med2022https://conductscience.org/library/papers/35646138PubMed
35586052Targeting HMGB1-NFκb Axis and miR-21 by Glycyrrhizin: Role in Amelioration of Corneal Injury in a Mouse Model of Alkali Burn.Front Pharmacol2022https://conductscience.org/library/papers/35586052PubMed
34904016Quercetin Reduces Oxidative Stress and Apoptosis by Inhibiting HMGB1 and Its Translocation, Thereby Alleviating Liver Injury in ACLF Rats.Evid Based Complement Alternat Med2021https://conductscience.org/library/papers/34904016PubMed
33192202Induced Pluripotent Stem Cells Attenuate Acute Lung Injury Induced by Ischemia Reperfusion via Suppressing the High Mobility Group Box-1.Dose Response2020https://conductscience.org/library/papers/33192202PubMed
32660524High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies.J Hematol Oncol2020https://conductscience.org/library/papers/32660524PubMed
32431618Quercetin Attenuates d-GaLN-Induced L02 Cell Damage by Suppressing Oxidative Stress and Mitochondrial Apoptosis via Inhibition of HMGB1.Front Pharmacol2020https://conductscience.org/library/papers/32431618PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCL26347PubTator's text mininghttps://conductscience.org/library/genes/6347NCBI Gene
HMGB13146PubTator's text mininghttps://conductscience.org/library/genes/3146NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MCL14170PubTator's text mininghttps://conductscience.org/library/genes/4170NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
TLR47099PubTator's text mininghttps://conductscience.org/library/genes/7099NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29436639

GET https://conductscience.org/api/papers/v1/29436639/authors